Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 19051-19100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06325813
ADHD PreSMA Response Inhibition Therapy
NARecruiting
40 participants
Started: Sep 3, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06556433
Family-Based Financial Incentives Intervention for Smoking Cessation
NARecruiting
1,312 participants
Started: Sep 3, 2024 · Completed: Jan 31, 2028
1 condition3 sponsors1 location
NCT06274801
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
PHASE3Recruiting
300 participants
Started: Sep 3, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor107 locations
NCT05590624
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer
NARecruiting
30 participants
Started: Sep 3, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06635798
A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection
PHASE3Recruiting
582 participants
Started: Sep 3, 2024 · Completed: Mar 4, 2025
1 condition1 sponsor20 locations
NCT06445608
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
NARecruiting
310 participants
Started: Sep 3, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor18 locations
NCT06384963
Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF
NARecruiting
54 participants
Started: Sep 2, 2024 · Completed: Apr 1, 2026
1 condition2 sponsors3 locations
NCT06471634
A Study Looking to Improve Sleep and Reduce Sedentary Behaviour in Those Living With Type 2 Diabetes Mellitus
NARecruiting
44 participants
Started: Sep 2, 2024 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT06565988
A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma
NARecruiting
125 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2025
1 condition2 sponsors7 locations
NCT06582576
Mechanisms of Action for the Enterra Medical Gastric Electrical Stimulator
N/ARecruiting
30 participants
Started: Sep 2, 2024 · Completed: Oct 1, 2025
3 conditions3 sponsors1 location
NCT06249126
Primary Subtalar Arthrodesis for Calcaneal Fractures
NARecruiting
218 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor16 locations
NCT06356025
Botulinum Toxin Injection in the UES for R-CPD
PHASE4Recruiting
30 participants
Started: Sep 2, 2024 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT06967168
HeEL Pain Pathways Feasibility Study
NARecruiting
50 participants
Started: Sep 2, 2024 · Completed: Nov 28, 2025
1 condition1 sponsor1 location
NCT06544785
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PHASE2Recruiting
106 participants
Started: Sep 2, 2024 · Completed: May 31, 2032
2 conditions1 sponsor1 location
NCT06565026
CS-206 in Patients With Sickle Cell Disease
EARLY_PHASE1Recruiting
5 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06215989
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
NARecruiting
6,574 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2028
5 conditions1 sponsor1 location
NCT06283719
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
PHASE1/PHASE2Recruiting
105 participants
Started: Sep 2, 2024 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT06292585
Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)
NARecruiting
194 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06579937
Effects of Esketamine on Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy
PHASE4Recruiting
172 participants
Started: Sep 2, 2024 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06575179
Dexmedetomidine Reduces Sevoflurane MAC-BAR During Pneumoperitoneum
PHASE4Recruiting
90 participants
Started: Sep 2, 2024 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05851534
Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas
NARecruiting
2,575 participants
Started: Sep 2, 2024 · Completed: Sep 2, 2028
4 conditions2 sponsors13 locations
NCT06612359
Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke
PHASE1Recruiting
12 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT06026592
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
N/ARecruiting
30 participants
Started: Sep 2, 2024 · Completed: Jul 9, 2026
2 conditions1 sponsor1 location
NCT06756438
Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NARecruiting
88 participants
Started: Sep 2, 2024 · Completed: Sep 1, 2025
2 conditions1 sponsor1 location
NCT06576271
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants
PHASE1Recruiting
138 participants
Started: Sep 2, 2024 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT06477536
Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
PHASE2/PHASE3Recruiting
33 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT06142682
Dexamethasone Eluting Cochlear Implant: a Pivotal Study
NARecruiting
60 participants
Started: Sep 2, 2024 · Completed: May 30, 2026
1 condition1 sponsor7 locations
NCT07114809
Impact of Anodal tDCS and Virtual Reality on Cognitive Dysfunction in Patients With Multiple Sclerosis
NARecruiting
80 participants
Started: Sep 2, 2024 · Completed: Jan 31, 2026
2 conditions2 sponsors3 locations
NCT07122960
Strengthening Informed Consent for Authentic Participation in Perinatal HIV Research
NARecruiting
60 participants
Started: Sep 2, 2024 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT06309641
Methemoglobinemia Following Intravenous Iron Treatment
N/ARecruiting
80 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06138990
Pharmacoscopy-guided Clinical Standard-of-care in r/r AML
PHASE2Recruiting
88 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2026
1 condition3 sponsors2 locations
NCT06594250
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
N/ARecruiting
405 participants
Started: Sep 2, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06590103
Effectiveness of Integrating Physically Active Learning Through Co-teaching in Extremadura: ACTIVA-MENTE Project
NARecruiting
800 participants
Started: Sep 2, 2024 · Completed: Jun 15, 2025
3 conditions2 sponsors1 location
NCT06598488
Beetroot Juice: A Natural Boost for Cardiovascular Health in Postmenopausal Women?
NARecruiting
20 participants
Started: Sep 2, 2024 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT06614790
Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.
N/ARecruiting
300 participants
Started: Sep 2, 2024 · Completed: Jan 7, 2026
1 condition1 sponsor12 locations
NCT06545812
Immune Response During the Conservative and Minimal Invasive Treatment of Pain Caused by Lumbar Disc Herniation
NARecruiting
128 participants
Started: Sep 2, 2024 · Completed: Mar 2, 2026
4 conditions1 sponsor1 location
NCT06667414
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
N/ARecruiting
600 participants
Started: Sep 2, 2024 · Completed: Sep 24, 2028
1 condition1 sponsor44 locations
NCT06641856
Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai
N/ARecruiting
300 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06576375
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
PHASE3Recruiting
70 participants
Started: Sep 2, 2024 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT06652087
Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
NARecruiting
40 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT06559501
Integrated Case Management for Burns Care in Pakistan
NARecruiting
1,146 participants
Started: Sep 2, 2024 · Completed: Oct 31, 2026
4 conditions2 sponsors11 locations
NCT06610305
Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
PHASE4Recruiting
75 participants
Started: Sep 2, 2024 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT06496958
Water Exchange and CO2 Insufflation with Abdominal Compression Device to Reduce Manual Assistance
NARecruiting
400 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2026
4 conditions3 sponsors2 locations
NCT06359379
Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
PHASE2Recruiting
54 participants
Started: Sep 2, 2024 · Completed: Feb 28, 2027
1 condition1 sponsor6 locations
NCT06812858
PD-1 Inhibitors Maintenance for cHL Post-autoHCT
PHASE2Recruiting
83 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2030
1 condition1 sponsor3 locations
NCT06581666
Current Awareness, Perspective and Knowledge on Social Egg Freezing
N/ARecruiting
200 participants
Started: Sep 1, 2024 · Completed: Sep 1, 2030
1 condition1 sponsor1 location
NCT07045532
Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI
N/ARecruiting
100 participants
Started: Sep 1, 2024 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT07044921
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
PHASE2Recruiting
30 participants
Started: Sep 1, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06560528
Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression
PHASE2Recruiting
40 participants
Started: Sep 1, 2024 · Completed: Sep 1, 2028
2 conditions1 sponsor2 locations
NCT06582641
Evaluation of Peer Group Connection - Middle School
NARecruiting
1,400 participants
Started: Sep 1, 2024 · Completed: Sep 14, 2028
1 condition5 sponsors1 location